CCND2 and colorectal carcinoma: Recent studies have shown that IDO1 inhibition can enhance the radiotherapy effect of CRC (28), miR-145 is a novel therapeutic target for CRC to overcome radiation resistance (29), JAK2/STAT3/CCND2 axis and COASY/PI3K signal mediate radiation resistance of CRC (30, 31).